Cherry James D, Karam Albert G
David Geffen School of Medicine, Mattel Children's Hospital at UCLA, Los Angeles, CA, USA.
Pediatr Infect Dis J. 2007 Oct;26(10):966-7. doi: 10.1097/INF.0b013e318141ffc2.
Administration of the discontinued diphtheria-pertussis-tetanus vaccine was occasionally associated with a hypotonic-hyporesponsive episode in infants. The whole bacterial cell pertussis component was the likely culprit. For this reason, an acellular pertussis component was developed and incorporated into a new vaccine commonly called diptheria-tetanus-acellular pertussis (DTaP). Administration of DTaP vaccine has been followed by remarkably few hypotonic or hyporesponsive episodes. This report describes one of these unusual events.
停用的白喉-百日咳-破伤风疫苗的接种偶尔会与婴儿的低张性低反应发作有关。全细菌细胞百日咳成分可能是罪魁祸首。因此,开发了一种无细胞百日咳成分,并将其纳入一种通常称为白喉-破伤风-无细胞百日咳(DTaP)的新疫苗中。接种DTaP疫苗后,低张性或低反应发作的情况非常罕见。本报告描述了其中一起不寻常的事件。